Best Biotech IPO Performance


20-Jun-2018 17:17 PM



     Been 21 years and 4 days since Sarepta Therapeutics Inc (SRPT)  went into Initial Public Offering (IPO).  Today was the company research and development day releasing the press report on positive preliminary results from the first three children dosed in the Phase 1/2a Gene Therapy. A "-- Significant decrease in levels of serum creatine kinase (CK), an enzyme biomarker strongly associated with muscle damage caused by Duchenne muscular dystrophy"

     Biotech IPO in 2018 stocks has been the hidden hot sector lately with the ARMO Biosciences (ARMO) see share soars 67% on $1.6 billion or $42.99 per share in buyouts by Eli Lilly (LLY) on May 20, 2018. ARMO Biosciences (ARMO) IPO was on January 26, 2018,  priced at $17.00 per share. Additionally, another big biotech IPO mover for 2018 is  Solid Biosciences Inc (SLDB)  see share soar over 70% intraday and closed up at $43.00 or +46.36% from positive of Sarepta Therapeutics Inc (SRPT). In out of curiosity, we want to look what other hot biotech IPO for 2018 and here are some names:

          2018 Biotech IPO                                   IPO price            Current Price (as of 6/19/18 close)

  1. Eolus Inc (EOLS)                                    $12.00               $32.66
  2. Biofrontera AG (BFRA)                           $9.88                  $13.35
  3. Homology Medicines Inc (FIXX)              $16.00                $19.06
  4. Arcus Biosciences Inc (RCUS)               $15.00                 $16.95
  5. Solid Biosciences Inc (SLDB)                  $16.00                $43.00
  6. Scholar Rock Holding Corp (SRRK)        $14.00                 $$25.60

Best of Biotech IPO Performance

                                                                           IPO Price                         Current price ($as of 6/18/2018 close)

  1. Sarepta Therapeutics Inc (SRPT)              $9.00 on 6/4/1997                 $143.93
  2. Bluebird bio Inc (BLUE)                             $17.00 June 19, 2013.            $177.80
  3. Spark Therapeutics Inc (ONCE)                $23.00 on Jan 30, 2015          $82.88
  4. KITE PHARMA, Inc (KITE)                        $17.00 on 6/20/2014               Buyout $180 (8/30/17)
  5. Alnylam Pharmaceuticals Inc (ALNY)        $6.00, on 5/28/2004                $104.62
  6. Regenxbio (RGNX)                                    $22.00 on 9/16/2015               $60.55
  7. Eagle Pharmaceuticals (EGRX)                 $15.00 on 2/14/2014                $75.31
  8. GW Pharmaceuticals PLC (GWPH)           $8.93 per ADS 5/1/2013           $148.93

   As can be seen, a long-term investment holding with great science will always reward investors at the end. Therefore, keep doing your research and due diligence. Be open-minded for the next biotech IPO and it could become a multi-bagger. 

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.